A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
Mehta NK, Pfluegler M, Meetze K, Li B, Sindel I, Vogt F, Marklin M, Heitmann JS, Kauer J, Osburg L, Zekri L, Bühring HJ, Mueller S, Hörner S, Baeuerle PA, Michaelson JS, Jung G, Salih HR.
Mehta NK, et al. Among authors: baeuerle pa.
J Immunother Cancer. 2022 Mar;10(3):e003882. doi: 10.1136/jitc-2021-003882.
J Immunother Cancer. 2022.
PMID: 35288466
Free PMC article.